Total Payments
$117,310
2024 Payments
$10,798
Companies
50
Transactions
867
Medicare Patients
3,971
Medicare Billing
$398,544
Payment Breakdown by Category
Other$84,713 (72.2%)
Food & Beverage$16,599 (14.1%)
Consulting$9,180 (7.8%)
Travel$6,497 (5.5%)
Education$320.66 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $84,713 | 43 | 72.2% |
| Food and Beverage | $16,599 | 793 | 14.1% |
| Consulting Fee | $9,180 | 4 | 7.8% |
| Travel and Lodging | $6,497 | 17 | 5.5% |
| Education | $320.66 | 10 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $83,625 | 200 | $0 (2024) |
| PFIZER INC. | $16,176 | 66 | $0 (2024) |
| Janssen Biotech, Inc. | $4,662 | 37 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,780 | 55 | $0 (2024) |
| UCB, Inc. | $1,556 | 18 | $0 (2024) |
| LEO Pharma Inc. | $1,072 | 78 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,000 | 46 | $0 (2024) |
| Lilly USA, LLC | $929.55 | 34 | $0 (2024) |
| GENZYME CORPORATION | $680.41 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $676.58 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,798 | 147 | ABBVIE INC. ($8,277) |
| 2023 | $11,463 | 108 | ABBVIE INC. ($8,528) |
| 2022 | $24,740 | 121 | ABBVIE INC. ($23,032) |
| 2021 | $9,641 | 97 | AbbVie Inc. ($8,505) |
| 2020 | $9,746 | 68 | AbbVie Inc. ($5,564) |
| 2019 | $26,085 | 116 | AbbVie, Inc. ($21,892) |
| 2018 | $18,877 | 131 | PFIZER INC. ($9,504) |
| 2017 | $5,959 | 79 | AbbVie, Inc. ($3,831) |
All Payment Transactions
867 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $9.28 | General |
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.69 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Immunology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.26 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Immunology | ||||||
| 11/13/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.29 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ACNE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,130 | 2,304 | $267,464 | $119,735 |
| 2022 | 13 | 1,097 | 2,048 | $210,240 | $109,163 |
| 2021 | 12 | 948 | 1,969 | $184,383 | $97,749 |
| 2020 | 12 | 796 | 1,644 | $139,623 | $71,897 |
Total Patients
3,971
Total Services
7,965
Medicare Billing
$398,544
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 351 | 523 | $112,884 | $51,666 | 45.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 211 | 298 | $35,066 | $14,516 | 41.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 99 | 118 | $21,391 | $10,373 | 48.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 36 | 52 | $15,458 | $7,956 | 51.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 60 | 68 | $13,781 | $6,497 | 47.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 22 | 23 | $12,419 | $6,390 | 51.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 171 | 1,015 | $12,018 | $6,120 | 50.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 30 | 37 | $18,210 | $5,091 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 75 | $11,422 | $4,965 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $11,942 | $4,651 | 38.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 32 | $2,874 | $1,508 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 419 | $77,858 | $40,065 | 51.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 193 | 255 | $25,932 | $12,284 | 47.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 99 | 111 | $17,545 | $9,545 | 54.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 30 | 32 | $14,836 | $8,362 | 56.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 66 | 73 | $12,764 | $7,226 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 76 | 90 | $11,903 | $6,849 | 57.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $11,788 | $5,619 | 47.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 152 | 878 | $9,096 | $5,528 | 60.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 26 | 27 | $6,935 | $4,062 | 58.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2022 | 24 | 26 | $10,927 | $3,459 | 31.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2022 | 11 | 12 | $5,691 | $3,301 | 58.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 28 | 28 | $3,005 | $1,623 | 54.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 19 | 25 | $1,960 | $1,239 | 63.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 269 | 377 | $70,868 | $36,404 | 51.4% |
About Dr. Todd Perkins, MD
Dr. Todd Perkins, MD is a Dermatology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982641148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Perkins, MD has received a total of $117,310 in payments from pharmaceutical and medical device companies, with $10,798 received in 2024. These payments were reported across 867 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($84,713).
As a Medicare-enrolled provider, Perkins has provided services to 3,971 Medicare beneficiaries, totaling 7,965 services with total Medicare billing of $398,544. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Washington, DC
- Active Since 05/31/2006
- Last Updated 07/12/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1982641148
Products in Payments
- SKYRIZI (Biological) $50,071
- EUCRISA (Drug) $16,079
- Skyrizi (Biological) $11,972
- Humira (Biological) $11,027
- Tremfya (Drug) $4,073
- RINVOQ (Biological) $3,589
- DUPIXENT (Biological) $1,353
- MIRVASO (Drug) $900.00
- TALTZ (Drug) $888.62
- ENSTILAR (Drug) $657.72
- OPZELURA (Drug) $456.16
- ADBRY (Biological) $380.31
- ILUMYA (Biological) $371.70
- VTAMA (Drug) $365.75
- COSENTYX (Biological) $347.42
- Sotyktu (Drug) $249.31
- Winlevi (Drug) $248.69
- ORACEA (Drug) $248.62
- TREMFYA (Drug) $248.47
- Bimzelx (Biological) $221.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Washington
Dr. Jonathan Silverberg, Md, Phd, Mph, MD, PHD, MPH
Dermatology — Payments: $4.9M
Dermatology $4.9M
Dr. Adam Friedman, M.d, M.D
Dermatology — Payments: $1.8M
Dermatology $1.8M
Dr. Terrence Keaney, M.d, M.D
Dermatology — Payments: $1.1M
Dermatology $1.1M
Dr. Candrice Heath, Md, MD
Dermatology — Payments: $214,277
Dermatology $214,277
Mary Ruth Buchness, Md, MD
Dermatology — Payments: $150,119
Dermatology $150,119
Dr. Yolanda Holmes, Md, MD
Dermatology — Payments: $107,834
Dermatology $107,834